← Back to Calendar
Live Company Data
NGM
Updated
5m ago
· Data: FMP
Current Price
$84.39
+45.93%
+$26.56 today
Day: $82.96 – $86.19
Market Cap
N/A
Shares out: 68.29M
Float: 55.45M
52-Week Range
Current price is at 43% of 52-week range
Sector
Healthcare
Biotechnology
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Q4 2025 earnings + IMCIVREE acquired HO PDUFA update
Key Notes
Q4 2025 earnings reported February 26, 2026. IMCIVREE Q4 revenue $57.3M (FY2025 $194.8M, +50% YoY). FDA PDUFA March 20, 2026 for acquired hypothalamic obesity (sNDA). EMA CHMP opinion expected Q2 2026. Phase 3 EMANATE topline data expected Q1 2026.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.